Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?"

E L Fosbøl; G H Gislason; L Køber; C Torp-Pedersen

doi:10.1038/clpt.2009.204

Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?"

E L Fosbøl, G H Gislason, L Køber, C Torp-Pedersen

Original language	English
Journal	Clinical Pharmacology and Therapeutics
Volume	86
Issue number	6
Pages (from-to)	602-604
Number of pages	3
ISSN	0009-9236
DOIs	https://doi.org/10.1038/clpt.2009.204
Publication status	Published - Dec 2009

Access to Document

10.1038/clpt.2009.204

Cite this

Fosbøl, E. L., Gislason, G. H., Køber, L., & Torp-Pedersen, C. (2009). Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?". Clinical Pharmacology and Therapeutics, 86(6), 602-604. https://doi.org/10.1038/clpt.2009.204

Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?". / Fosbøl, E L ; Gislason, G H ; Køber, L et al.
In: Clinical Pharmacology and Therapeutics, Vol. 86, No. 6, 12.2009, p. 602-604.

Research output: Contribution to journal › Letter › peer-review

Fosbøl, EL , Gislason, GH , Køber, L & Torp-Pedersen, C 2009, 'Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?"', Clinical Pharmacology and Therapeutics, vol. 86, no. 6, pp. 602-604. https://doi.org/10.1038/clpt.2009.204

Fosbøl EL , Gislason GH , Køber L , Torp-Pedersen C. Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?". Clinical Pharmacology and Therapeutics. 2009 Dec;86(6):602-604. doi: 10.1038/clpt.2009.204

Fosbøl, E L ; Gislason, G H ; Køber, L et al. / Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?". In: Clinical Pharmacology and Therapeutics. 2009 ; Vol. 86, No. 6. pp. 602-604.

@article{9f7274dc9e504c10825046ae5a5ecdd4,

title = "Response to {"}No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs,{"} {"}Do NSAIDs Actually Protect Against Myocardial Infarction and Death?,{"} and {"}Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?{"}",

author = "Fosb{\o}l, {E L} and Gislason, {G H} and L K{\o}ber and C Torp-Pedersen",

year = "2009",

month = dec,

doi = "10.1038/clpt.2009.204",

language = "English",

volume = "86",

pages = "602--604",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?"

AU - Fosbøl, E L

AU - Gislason, G H

AU - Køber, L

AU - Torp-Pedersen, C

PY - 2009/12

Y1 - 2009/12

U2 - 10.1038/clpt.2009.204

DO - 10.1038/clpt.2009.204

M3 - Letter

C2 - 28547832

SN - 0009-9236

VL - 86

SP - 602

EP - 604

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 6

ER -